Sunday, September 21, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

ABN Amro Stock: Profit Dip Amid Strong Capital Moves

Robert Sasse by Robert Sasse
August 6, 2025
in Stocks
0
ABN Amro Stock
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Dutch banking giant ABN Amro reported a 6% decline in Q2 net profit to €606 million, down from €642 million a year earlier, citing lower interest income as a key factor. The bank’s net interest income fell 5% to €1.53 billion, with its margin narrowing to 149 basis points. However, fee-based income rose 6% to €492 million, driven by revised pricing in retail banking. Despite the profit drop, ABN Amro announced a €250 million share buyback program, starting August 7, backed by a robust CET1 capital ratio of 14.8%.

Strategic Growth Amid Challenges

The bank’s mortgage portfolio grew by €1.8 billion to €160 billion, reflecting resilience in the Dutch housing market. ABN Amro also confirmed an interim dividend of €0.54 per share, payable in September. Strategic moves included completing a German wealth management acquisition and plans to launch a neobank targeting younger customers. The bank maintained its full-year cost guidance of €5.3–5.4 billion, with further capital optimization plans slated for Q4.

Ad

ABN Amro Stock: Buy or Sell?! New ABN Amro Analysis from September 21 delivers the answer:

The latest ABN Amro figures speak for themselves: Urgent action needed for ABN Amro investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 21.

ABN Amro: Buy or sell? Read more here...

Tags: ABN Amro
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Quantum Computing Stock
Stocks

Quantum Computing Stock Dips Despite Major Contract Wins

September 16, 2025
Coinbase Stock
Stocks

Institutional Partnership Fuels Optimism for Coinbase’s Future

September 16, 2025
Strategy Stock
Stocks

MicroStrategy’s Bitcoin Bet Faces Market Skepticism

September 16, 2025
Next Post
Beiersdorf Stock

Beiersdorf Stock: Nivea's Glow Fades as Forecasts Dim

Fresenius Stock

Fresenius Stock: Mixed Q2 Results Amid Margin Pressures

Walt Disney Stock

Walt Disney Stock: Marvel Woes Offset by NFL Deal

Recommended

Lululemon Stock

Lululemon Shares Face Mounting Analyst Doubts as Growth Stalls

1 month ago
Investings on laptop and finances

Analyzing the Rise and Potential Fall of AMD Stock

2 years ago
Healthcare Services Stock Exchange

Title Taysha Gene Therapies to Present Groundbreaking Clinical Data on TSHA102 for Rett Syndrome at British Paediatric Neurology Association 2024 Annual Conference

2 years ago
Broadcom Stock

Broadcom Stock Soars to Unprecedented Heights on AI-Driven Performance

2 weeks ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla Tilray TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

OMV Faces Dual Challenges: Espionage Scandal and Major Restructuring

EssilorLuxottica Shares Gain Momentum on AI Eyewear and Analyst Upgrade

LexinFintech Shares Garner Bullish Outlook Despite Recent Pullback

Viking Therapeutics Stock Stages Impressive Recovery

Fiserv Faces Investor Backlash Amid Clover Platform Concerns

Key Financial Executive Departs Conagra Brands Ahead of Earnings

Trending

Union Pacific Stock
Industrial

Political Backing Fuels Speculation Over Major Railroad Merger

by Dieter Jaworski
September 21, 2025
0

A potential $85 billion consolidation between Union Pacific and Norfolk Southern has received unexpected presidential endorsement, though...

Century Therapeutics Stock

Is Century Therapeutics Stock a High-Stakes Turnaround Play?

September 21, 2025
Groupon Stock

Groupon Shares Surge as Analysts Issue Bullish Upgrades

September 21, 2025
OMV PK Stock

OMV Faces Dual Challenges: Espionage Scandal and Major Restructuring

September 21, 2025
Essilor International Stock

EssilorLuxottica Shares Gain Momentum on AI Eyewear and Analyst Upgrade

September 21, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Political Backing Fuels Speculation Over Major Railroad Merger
  • Is Century Therapeutics Stock a High-Stakes Turnaround Play?
  • Groupon Shares Surge as Analysts Issue Bullish Upgrades

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com